tolvaptan has been researched along with dapagliflozin in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (dapagliflozin) | Trials (dapagliflozin) | Recent Studies (post-2010) (dapagliflozin) |
---|---|---|---|---|---|
967 | 172 | 786 | 1,478 | 368 | 1,407 |
Protein | Taxonomy | tolvaptan (IC50) | dapagliflozin (IC50) |
---|---|---|---|
Sodium/glucose cotransporter 1 | Homo sapiens (human) | 1.1661 | |
Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0022 | |
Sodium/myo-inositol cotransporter 2 | Homo sapiens (human) | 0.38 | |
Solute carrier family 5 member 4 | Homo sapiens (human) | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, T; Imai, T; Maeshima, A; Masuda, T; Miki, A; Miyazawa, Y; Murakami, T; Muto, S; Myoga, A; Nagata, D; Nakagawa, S; Ohara, K; Okada, M; Saito, O; Sekiguchi, C; Sugase, T; Yoshizawa, H | 1 |
1 other study(ies) available for tolvaptan and dapagliflozin
Article | Year |
---|---|
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzhydryl Compounds; Body Composition; Female; Fluid Shifts; Furosemide; Glucosides; Humans; Male; Prospective Studies; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2019 |